Detalles de la búsqueda
1.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine;
62: 102109, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533419
Resultados
1 -
1
de 1
1
Próxima >
>>